þ ´ e z Ì J h g O Y / ?ÌÂDW ´ þ J h g O Y p ° / ? ª · J h g O Y p ° 0I Ø M G k e F c Qê W M¤ ð Ì : ³ 8 Ú Û Ï ´ ¾ µ Ø [, ; \ c M G k e F c Qê M¤ È ð Ì

$Page 1: þ ´ e z Ì J h g O Y / ?ÌÂDW ´ þ J h g O Y p ° / ? ª · J h g O Y p ° 0I Ø M G k e F c Qê W M¤ ð Ì : ³ 8 Ú Û Ï ´ ¾ µ Ø [, ; \ c M G k e F c Qê M¤ È ð Ì$
Sola City Hall

Ø 

(Material-mediated Pyrogens)

Lipopolysaccharide, LPS

Ø Ø 

Ø Ø Ø 

Ø Ø 

Ø 

Ø 

Ø 

Ø 

��

Ih_ilj`^p IV8LL Nch`mc^8THO *)1 SpkiVg\km SpkiJ`h` Ih_i[pg` *)1 HY< Il^b`kc^bc\6îfcqR@@q��w�� A7 B7 <@7 ?<7 <7 >7 B7 =@7 >;7

= Il^b`kc^bc\6îfc6R<<<6��w�� @7 ?7 @7 =<7 A7 =7 <;7 =<7 <D7

> Il^b`kc^bc\6îfc6R@@q�-/�� <>7 >D7 >?7 BD7 D7 ==7 =<7 >D7 @?7

? Il^b`kc^bc\6îfc6R<<<6�-/�� <?7 ;7 =B7 B@7 <7 <<7 <=7 <@7 ??7

@ Il^b`kc^bc\6îfc6R<<>6�-/�� <>7 C7 =@7 D=7 <>7 ==7 <=7 <A7 @>7

A Il^b`kc^bc\6îfc6R<@;6�-/�� ?7 >7 <B7 C;7 <7 <7 @7 AD7 <;=7

B Sikjbpkigih\l6achaco\fcl6FWHH6>>=BB <7 B7 B7 ?=7 <7 =7 @7 =;7 @A7

C V\fgih`ff\6gchh`lim\6<<<? <7 <=7 <>7 BA7 <7 =?7 C7 ?=7 C=7

D V\fgih`ff\6gchh`lim\6U@D@ <<A7 A<7 <=B7 AA7 <;@7 <=B7 <>=7 <C7 ?<7

<; Sl`n_igih\l6\`knachil\6SF;< B7 <@7 =@7 <==7 <;7 <>7 =7 <>7 AB7

<< K`fcî]\^m`k6jpfikc6JX= =@7 >?7 <?7 <DB;7 =A7 @7 <<7 <;C<7 ><DB7

<= Skim`nl6onfa\kcl6RZ= =7 =7 <C7 C7 C7 <;7 <?7 A7 D7

<> H\gjpfi]\^m`k6d`dnhc6S`hh`k6RE<D >7 <;7 ?7 <D7 ;7 <7 B;7 =A7 =?7

<? Il^b`kc^bc\6îfc6R<=CEG<= =D7 <=7 >@7 <?7 =C7 <D7 <>7 >>7 >;7

<@ Il^b`kc^bc\6îfc6M@ =<7 C7 =?7 <@<7 >=7 D7 @7 @=7 <;A7

<A V\fgih`ff\6`hm`kc^\6l`kimpj`6mpjbcgnkcng >7 <<7 C7 C7 B7 =;7 <<7 D7 <?7

<B Sl`n_igih\l6\`knachil\6<; >7 ?7 =;7 <>C7 C7 <7 >7 B@7 <<C7

<C Nf`]lc`ff\6jh`ngihc\` =A7 =7 >D7 >7 ><7 =@7 =B7 <@7 <=7

<D Gnkebif_`kc\6^`j\^c\ =7 @D7 @7 =C7 >A7 @@7 =A7 <<D7 BA7

=; V`kk\mc\6g\k^`l^`hl6'A;;6IX:gO >7 =7 =;7 <=7 <<7 @7 <<7 <<?7 C;7

=< U\flmihc\6jcê`mmcc6'>;;6IX:gO ?7 @7 <D7 >;7 <?7 A7 <=7 <=<7 B=7

== Ihm`ki]\^m`k6^fi\^\`6'<?;;6IX:gO <7 <7 =;7 ==7 =7 @7 <?7 <<C7 B?7

=> Il^b`kc^bc\6îfc6�>76hnmkc`hm6]kimb�6'B;;6IX:gO <;7 A7 =>7 C7 A7 C7 <7 ?A7 =C7

=? Sl`n_igih\l6\`knachil\6'C;;;6IX:gO <B7 >7 <A7 >=7 A7 C7 @7 <B7 =>7

=@ ��(&��5%��<;;�@;;6IX:gO C7 B7 ?7 =>7 B7 =7 A7 ?A7 A;7

=A ��"%��(&��5%��6<;;�@;;6IX:gO ?7 A7 B7 <?7 ;7 =7 B7 ?;7 ><7

=B ��0��2��2��6<;;�@;;6IX:gO C7 A7 ==7 ==7 D7 A7 ;7 @B7 B;7

=C ��$��(&��5%��6<;;�@;;6IX:gO <D7 @7 D7 ==7 =7 D7 ?7 >?7 >A7

=D �+�~��vx�{�q��r� �qq;9=�;9>6IX:gO =D7 =C7 >=7 <<7 =>7 <@7 =@7 C?7 DA7

>; �.�6�SPUM#!�4 �st��6<;�=;6IX:gO @;7 BB7 AC7 >;7 ?C7 ?>7 @=7 <D<7 <?=7

OSV

QRI

��uz�|*)6HY �y��}�|*)6HY,q�Qi9�3

Ø Ø Ø 

Ø 

1.  Kikuchi, Y. et al., Collaborative Study on the Bacterial Endotoxins Test Using Recombinant Factor C-based Procedure for Detection of Lipopoly-saccharides. Pharmaceutical and Medical Device Regulatory Science 48 (4), 252-260 (2017) .

2.  Kikuchi, Y. et al., Collaborative Study on the Bacterial Endotoxins Test Using Recombinant Factor C-based Procedure for Detection of Lipopoly-saccharides, Part 2. Pharmaceutical and Medical Device Regulatory Science 49 (10), 706-718 (2018) .



��

�



��

��

K (EU/kg)

5.0

2.5

0.5

5.0

Ø  pH Ø  Ø  EDTA 4Na

Ø Ø 

Ø 

Ø 

 

65��&�02��)$� ��

�

��

��

��

!�

��

��

� ! �� ! ��

��49:5

0/1

,

��

�43

5

75�%'(��+1-.2

�

��

��

��

!�

��

��

� ! �� ! ��

��49:5

0/1

,

��

�43

5

85�%'(��'"#

�

��

��

��

!�

��

��

� ! �� ! ��

��49:5

0/1

,

��

�43

5

�� *�� *�� *!�

JPSE 10 EU/mL JPSE 0.025 EU/mL RO

Chen, J., Low Endotoxin Recovery in Common Biologics Products. Presented at PDA 8th Annual Global Conference on Pharmaceutical Microbiology,

Bethesda, MD, (2013).

Ø  ( ) Na NaLER

Ø  LER

��

MeasureSpikeDilutionSample

MeasureSpike DilutionSampleLER

Ø 

Ø 

¨¾� KÉÉÉr ¨¾� KÉÉÉr

�

¦¾Å��¾½³µ½ÂÀ±Â¹¾½�ª¬��±ÃÁµ´�¦¡«�«µ±³Â¹¾½�¹½�Â¸µ�ªÀµÁµ½³µ�¾¶§¾½¾³»¾½±»��½Â¹²¾´Ç�ªÀ¾´Ã³Âĕ�X5áª¬��ė��ĘÞ¼�²â�\Ýâ¦¡«îyÕÖßÍĕ�lî�`ØìÞÊ¼�²X5.cà¦¡«^wÒyÕìĕ�¬¡Ýâ¦¡«ÒyÕìÒÊ¨©¡ÝâyÕêßÍ

�

§±¿¿¹½·�¦¡«�¡¶¶µ³Â�¹½�¤½�ªÀ¾³µÁÁ�¬Â±·µÁ�¾¶�ªÃÀ¹¶¹³±Â¹¾½ĕ�n#qzá M�àÐÍÜ¦¡«ÒvçêíÚDáĐý÷t�0BAQĕõðĄďðĔfàPÛÜ¦�¦u�î0BØìĕ:rßu�áåî0BØìĕ¨©¡î`Øì

�

®Áµ�¾¶�ªÃÀ¹¶¹µ´�±½´�¨¾½¿ÃÀ¹¶¹µ´�¡½´¾Â¾Æ¹½Á�¹½�£¾»´�Â¹¼µ�¬ÂÃ´¹µÁĕgqòĔĄăöûĔ�ã¨©¡Þèà¦¡«ÒyÕë9ìĕòĔĄăöûĔáh5éëèÊ'�G�á8�î�Ôìė§·��X5ÊV5Ęĕ«¬¡á`î>,

�

¢±³Â¾ÀÁ��¶¶µ³Â¹½·�¦¾Å�¡½´¾Â¾Æ¹½�«µ³¾ÄµÀÇĕ÷òĔ}�ª¬��àéì¦¡«âÊV5Ê¿£Ê*X5á8�î�Ôìĕ�VÊ�¿£Ê�*X5G�àéë¦¡«Ò�Uĕ�¼§�§·¬©�àéìúĔċđ4~î>,

��¾¼¿±À¹Á¾½�¾¶� ¹¶¶µÀµ½Â�§µÂ¸¾´Á�®Áµ´�¶¾À��±»³Ã»±Â¹¾½�¾¶�ªµÀ³µ½Â¹»µ¡½´¾Â¾Æ¹½�«µ³¾ÄµÀÇ�¶À¾¼�¦ª¬�¬¿¹ºµ´��¹¾»¾·¹³±»�¸µÀ±¿µÃÂ¹³�ªÀ¾´Ã³ÂÁĕ£¾»´�Â¹¼µ�ÁÂÃ´Çá�;3ZÞ×ÜâÊ¦«¯Ñêá¦ª¬%��Ò�íÜÍì

�

¦¹¿¾¿¾»ÇÁ±³³¸±À¹´µ�§±Áº¹½·�±½´�«µÁ¾»ÃÂ¹¾½�¾¶�¦¾Å�¡½´¾Â¾Æ¹½��¦¹¿¾¿¾»Ç�Á±³³¸±À¹´µ�«µ³¾ÄµÀÇ��¦¡«�¦¦«��¹½�±��¹ÂÀ±Âµ��Ã¶¶µÀ�§¾½¾³»¾½±»��½Â¹²¾´Ç³¾½Â±¹½¹½·�ª¾»ÇÁ¾À²±Âµ�±½´��¸µ»±Â¹½·��·µ½Âĕ��¼§�÷òĔ}Ê��¼§�*�ąăĐñĎÊ��µ§� ª�Ê��ª¬��î"æ��¼�²q�ė��¼·�¼¦��¿£��Ęà�¬¡îýĉð÷ØìÞ¦¡«ÒyÕìĕ¨©¡ÝâÊ¦¡«ÒyÕêßÍĕ�¬¡á¦¡«^wâÊu��-��à��¼§�§·¬©�"E��¼§�À¹Á�â��¼§�§·¬©�"E��¼§�À¹ÁÝÊúĔċđî�� â�� 4~ØìÕÞà�éë?$ØìË

�¡Ä±»Ã±Â¹¾½�¾¶�±½�¡½´¾Â¾Æ¹½� µ¼±Áº¹½·�ªÀ¾Â¾³¾»ĕ¦¡«á%|QÞ×ÜÊ¡½´¾�«¬�¥¹Âî`×Úċēăùđî�<ĕu�V5â��È��î>,

�

¬ÂÀ±Âµ·Ç�Â¾�¹½ÄµÁÂ¹·±Âµ�±½´�¾ÄµÀ³¾¼µ�¦¡«�´À¹Äµ½�²Ç�¿À¾Âµ¹½ĕª¬fî"äßÍ)!ÝèÊ¦¡«îyÕØÿĔĉ÷q�ÒÌìĕ¦ª¬áT�DFî+�ÖÙÚĐĈĖýýÿĂïàéëÊW/Ná+�î%|ĕ��ÈÝu�îoÎÕÞàéëÊ¦¡«ÒsRÖíì

�

¦¡«��±Áµ�¬ÂÃ´Ç�¶¾À�±�§¾½¾³»¾½±»��½Â¹²¾´Çĕ¡ �Êª¬��"E¼�²q�âÊ«¬¡Þ�¬¡Ý¦¡«ÒyÕìÒÊ¨©¡ÝâyÕ�êßÍĕ¼�²�\Ýâ¦¡«ÒyÕêßÍĕ«¬¡Þ�¬¡âÊ¡ �"EĊýĀüĔ�ăĒćēĖýjpSė¿£��ĘÝ¦¡«Ò�yÕìė�&[xę¡ �ÊĊýĀüĔĘĕª¬��¿£��â�¬¡á%�]î?$Øìė��Dáå�Ñà�2Ęĕ�@�Ê��ôĀóĔÊ}Ê*(fá��_â�ÜY�ĕ¦�¦unáe�àéëÊ¦¡«75Òbßì

��

¡½´¾Â¾Æ¹½�«µ³¾ÄµÀÇ�¬ÂÃ´¹µÁ�Å¹Â¸�±��¹¾»¾·¹³�¢¾À¼Ã»±Âµ´�Å¹Â¸��¹ÂÀ±Âµ�±½´ª¾»ÇÁ¾À²±Âµ��ĕ÷òĔ}Êª¬��î"EØìq�°â�¬¡á¦¡«î6ÓyÕØÒÊ÷òĔ}Ê��ª¬��î"äßÍ�nĒČđÝâ¦¡«ÒyÕêßÍĕJ[��IaH¨©¡ÝâyÕêßÍĕ�¬¡Þ¨©¡á¦¡«=�á{Íâ¦ª¬Lzád{àaHØìÞkÏêíìĕ¦¡«îyÕÖßÍCÍM�Ýt�ØìÞmÍėċēþýùĔăēĖđĘ

��

¨¾�¦¡«�¡¶¶µ³Â�¹½�±�¬¾´¹Ã¼�ª¸¾Á¿¸±Âµ��ª¾»ÇÁ¾À²±Âµ��¢¾À¼Ã»±Â¹¾½�§±ÂÀ¹Æĕ��¼·�¼¦áÿĔĉ÷xėĚ¤��î"æĐĔ}ąăĐñĎ�ª¬��čĔĆ�ăĖđjpSė��¼§��¿£��à«¬¡îT�×Ê1V�.×Üè�¦¡«âyÕêßÍ

��

¦±³º�¾¶�¦¡«�ª¸µ½¾¼µ½¾½�¹½��¸µÀ±¿µÃÂ¹³�ªÀ¾Âµ¹½��¹¾»¾·¹³�Å¹Â¸�¥½¾Å½¦¡«��±ÃÁ¹½·�¤½·Àµ´¹µ½ÂÁĕĊăøĐùċēāðĔė¿¤��Ê��¼§�¦�ĊýĀüĔÊ��ª¬��î"æĐ��Ĕ}�OiąăĐñĎjpSė¿£��à�¬¡îT�×Üè¦¡«âyÕêßÍ

RSE: Reference Standard Endotoxin, CSE: Control Standard Endotoxin, NOE: Naturally Occurring Endotoxin


�


�


�


�



�



�


�


��


��


��




�


�


�


�



�



�


�


��


��


��




�


�


�


�



�



�


�


��


��


��




�


�


�


�



�



�


�


��

¡½´¾Â¾Æ¹½�«µ³¾ÄµÀÇ�¬ÂÃ´¹µÁ�Å¹Â¸�±��¹¾»¾·¹³�¢¾À¼Ã»±Âµ´�Å¹Â¸��¹ÂÀ±Âµ�±½´ª¾»ÇÁ¾À²±Âµ��ĕ÷òĔ}Êª¬��î"EØìq�°â�¬¡á¦¡«î6ÓyÕØÒÊ÷òĔ}Ê��ª¬��î"äßÍ�nĒČđÝâ¦¡«ÒyÕêßÍĕJ[��IaH¨©¡ÝâyÕêßÍĕ�¬¡Þ¨©¡á¦¡«=�á{Íâ¦ª¡Lzád{àaHØìÞkÏêíìĕ¦¡«îyÕÖßÍCÍM�Ýt�ØìÞmÍėċēþýùĔăēĖđĘ

��


��



Ø Ø Ø Ø 

Ø Ø Ø Ø 

LPS LPS

MF

Work described in Case Study #3, “Use of Purified and Non-purified Endotoxins in Hold-time Studies”, has shown that masking susceptibility depends on the bacterial species and that culture conditions do affect the masking susceptibility of endotoxins. Additionally, this work demonstrated that isolation methods do not alter the primary structure of the lipid A profiles (i.e., lipid A profiles from NOEs are similar to their highly purified counterparts); however, the supramolecular structures of endotoxin may be influenced by the preparation method.

NOE

RSE, CSE

TLR 1/2, 2/6 LTA, LP, etc. TLR 3 Viral double-stranded RNA TLR 4 LPS TLR 5 Bacterial flagellin TLR 7,8 Small synthetic antiviral molecule, RNA TLR 9 CpG DNA

Toll-Like Receptor (TLR) family

LBP LPS

sCD14

TLR4

MD2

TLR4

MD2

TLR2

mCD14 mCD14

PGN

MyD88IRAKTRAF6IKK

NF-κΒ activation

TIR TIRTIR

Induction of inflammatory cytokines such as IL-1, IL-6, TNFα

LTA

Schwarz H, et al. Scientific Report, 7:44750 (2017)

� ��

� ��

��

α β

Endotoxin

β(1,3)-D-glucanFactor C Activated Factor C

Activated Factor G Factor GFactor B

Activated Factor B

Proclotting Enzyme Clotting Enzyme Gelation ��

Boc-Leu-Gly-Arg-pNA � ��

Boc-Leu-Gly-Arg + pNA (OD 405 nm) � ��

Diazo-coupling (OD 545 nm) � ��

��

Endotoxin

β(1,3)-D-glucanFactor C Activated Factor C

Activated Factor G Factor GFactor B

Activated Factor B

Proclotting Enzyme Clotting Enzyme Gelation ��

Boc-Leu-Gly-Arg-pNA � ��

Boc-Leu-Gly-Arg + pNA (OD 405 nm) � ��

Diazo-coupling (OD 545 nm) � ��

��

HCPT

Ø Ø Ø Ø Ø 

Ø Ø 

Ø 

Ø 

Ø 

Ø 

Ø 

Ø 

Ø Ø 

Ø 


Documents

þ ´ e z Ì J h g O Y / ?ÌÂDW ´ þ J h g O Y p ° / ? ª · J h g O Y p ° 0I Ø M G k e F c Qê W M¤ ð Ì : ³ 8 Ú Û Ï ´ ¾ µ Ø [, ; \ c M G k e F c Qê M¤ È ð Ì